Yong Ho Kim
Affiliations: | Seoul National University, Seoul, South Korea |
Area:
Pain, TRP channelGoogle:
"Yong Ho Kim"Mean distance: 15.58 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentorR Alan North | grad student | 2008-2009 | University of Manchester |
Seog Bae Oh | grad student | 2006-2012 | Seoul National University |
Seog Bae Oh | post-doc | 2012- | Seoul National University |
Sung Jun Jung | research scientist | Seoul National University | |
Ru Rong Ji | research scientist | 2013- | Duke Medical School |
Hidemasa Furue | research scientist | 2013-2013 | National Insitute for Physiological Sciences, Japan |
Collaborators
Sign in to add collaboratorChul-Kyu Park | collaborator | Seoul National University | |
Gehoon Chung | collaborator | 2006- | Seoul National University |
Jinsoo Seo | collaborator | 2006- | Seoul National University |
Alexander J. Davies | collaborator | 2008- | University of Manchester |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Go EJ, Lee JY, Kim YH, et al. (2024) Site-Specific Transient Receptor Potential Channel Mechanisms and Their Characteristics for Targeted Chronic Itch Treatment. Biomolecules. 14 |
Park TH, Kim SK, Phi JH, et al. (2023) Survival and Malignant Transformation of Pineal Parenchymal Tumors: A 30-Year Retrospective Analysis in a Single-Institution. Brain Tumor Research and Treatment. 11: 254-265 |
Park J, Roh J, Pan J, et al. (2023) Role of Resolvins in Inflammatory and Neuropathic Pain. Pharmaceuticals (Basel, Switzerland). 16 |
Yang JY, Byun YH, Kim MS, et al. (2023) Factors limiting complete resection in the subarachnoid space in endoscopic surgery for giant pituitary adenoma. World Neurosurgery |
Nam JH, Yeo CD, Park CK, et al. (2023) Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy. Thoracic Cancer |
Dho YS, Lee BC, Moon HC, et al. (2023) Validation of real-time inside-out tracking and depth realization technologies for augmented reality-based neuronavigation. International Journal of Computer Assisted Radiology and Surgery |
Kim KM, Byun YH, Kang H, et al. (2023) Changes of resection goal after using 3D printing brain tumor model for presurgical planning. World Neurosurgery |
Rahman MM, Lee JY, Kim YH, et al. (2023) Epidural and Intrathecal Drug Delivery in Rats and Mice for Experimental Research: Fundamental Concepts, Techniques, Precaution, and Application. Biomedicines. 11 |
Park CK, Oh HJ, Kim YC, et al. (2023) Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
Park CK, Jeon N, Park HK, et al. (2023) A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer. Cancers. 15 |